NxGenPort
2 known investors
Find your way into NxGenPort
65 people in our graph share verified history with the NxGenPort team — schools, employers, funds. One of them is your warm intro.
Herman Verrelstunlockedknows Rosanne Welcher · together at Agilent Technologies (overlapped)
×10knows the team · via Agilent Technologies
knows the team · via University of La Verne
NXgenPort is developing a smart implantable chemotherapy port that integrates optical sensing and machine learning to monitor blood cell dynamics and other physiological changes in vivo, paired with a digital health platform for data analysis. It targets oncology care teams and cancer patients, aiming to detect treatment complications like infection and neutropenia early for remote patient monitoring.
Founders & leadership
CS
Cathy SkinnerCo-founder/Co-inventor & Chief Executive Officer
RW
Rosanne WelcherinCo-founder/Co-inventor & Chief Operating OfficerShe brings expertise in companion diagnostics, in vitro diagnostics development, regulatory affairs, and oncology.
Investors · 2
Frequently asked questions
- What does NxGenPort do?
- NXgenPort is developing a smart implantable chemotherapy port that integrates optical sensing and machine learning to monitor blood cell dynamics and other physiological changes in vivo, paired with a digital health platform for data analysis. It targets oncology care teams and cancer patients, aiming to detect treatment complications like infection and neutropenia early for remote patient monitoring.
- Who founded NxGenPort?
- NxGenPort was founded by Cathy Skinner, Rosanne Welcher.
- Who are NxGenPort's investors?
- NxGenPort's investors include Cancer Fund, GROOVE CAPITAL.